Drugmakers still struggling to keep up with spiking estrogen patch demand
The pharmaceutical industry is warning that estrogen patches continue to be in shortage in the U.S. as manufacturers struggle to keep up with increased demand linked to federal policy changes issued earlier this year, even as regulators have yet to recognize a lack in supply. Manufacturers first reported issues with supplying demand earlier this year...
We haven't written up this one. The Hill has the full story — the link below goes straight to it.
